Literature DB >> 1928147

Detection methods and strategies for improving medication compliance.

W S Bond1, D A Hussar.   

Abstract

The reliability of compliance detection methods and practical strategies for improving patient compliance with drug therapy are reviewed. Detection of noncompliance is a necessary prerequisite for adequate treatment. Noncompliance can be detected by indirect methods (e.g., self-report, interview, therapeutic outcome, pill count, computerized compliance monitors) or direct methods (e.g., biologic markers, tracer compounds, biologic assay of body fluids). In general, the direct methods of detection have a higher sensitivity and specificity than the indirect methods. Computerized compliance monitors are the most recent and reliable of the indirect-detection methods. Strategies for improving compliance involve identification of risk factors for non-compliance; development, with the patient's participation, of an individualized treatment plan that simplifies the regimen as much as possible; education of the patient, including information about his or her illness, instructions on how to take the prescribed medication correctly, and an explanation of the benefits and possible adverse effects of the therapy; and, if necessary, use of compliance aids such as medication calendars, special containers, caps, and dispensing systems, or compliance packaging. The patient should be taught to monitor his or her own treatment regimen. Follow-up monitoring by health-care professionals, including pharmacists, will also help ensure that the patient is complying with the treatment regimen. Health-care practitioners need to understand factors that contribute to noncompliance and to use effective methods for assessing and monitoring compliance in conjunction with strategies aimed at increasing compliant behavior.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1928147

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  31 in total

1.  Is adherence to drug treatment correlated with health-related quality of life?

Authors:  Isabelle Côté; Karen Farris; David Feeny
Journal:  Qual Life Res       Date:  2003-09       Impact factor: 4.147

Review 2.  From compliance to concordance in diabetes.

Authors:  J S Chatterjee
Journal:  J Med Ethics       Date:  2006-09       Impact factor: 2.903

Review 3.  Modeling and simulation of adherence: approaches and applications in therapeutics.

Authors:  Leslie A Kenna; Line Labbé; Jeffrey S Barrett; Marc Pfister
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

4.  Increased focus on the teaching of interactional skills to medical practitioners.

Authors:  J J Perkins; R W Sanson-Fisher
Journal:  Adv Health Sci Educ Theory Pract       Date:  1996-01       Impact factor: 3.853

5.  Correlates of Medication Adherence in the TODAY Cohort of Youth With Type 2 Diabetes.

Authors:  Lorraine Levitt Katz; Barbara J Anderson; Siripoom V McKay; Roberto Izquierdo; Terri L Casey; Laurie A Higgins; Aimee Wauters; Kathryn Hirst; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2016-06-28       Impact factor: 19.112

6.  "Strong medicine": Cambodian views of medicine and medical compliance.

Authors:  J Shimada; J C Jackson; E Goldstein; D Buchwald
Journal:  J Gen Intern Med       Date:  1995-07       Impact factor: 5.128

7.  New medication adherence scale versus pharmacy fill rates in seniors with hypertension.

Authors:  Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner
Journal:  Am J Manag Care       Date:  2009-01       Impact factor: 2.229

Review 8.  Medication non-adherence in the elderly: how big is the problem?

Authors:  Carmel M Hughes
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 9.  Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature.

Authors:  Monique van Eijken; Sui Tsang; Michel Wensing; Peter A G M de Smet; Richard P T M Grol
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate.

Authors:  L Bellamy; N Rosencher; Bi Eriksson
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.